“ Dr. Richard Garfinkle presented the protocol of the ongoing SPECTRI trial to eye specialists in Northern Virginia. SPECTRI is an ongoing clinical trial examining the role of lampalizumab for the treatment of geographic atrophy in macular degeneration. This represents the first major, interventional trial in dry macular degeneration. The Retina Group of Washington is the only practice in the DC metropolitan area participating in this pivotal, cutting-edge trial. “
For more about SPECTRI trial click here.